Influence of 3-{5-[4-(diethylamino)benzylidene]-rhodanine}propionic acid on the conformation of 5-(4-chlorobenzylidene)-2-(4-methylpiperazin-1-yl)-3H- imidazol-4(5H)-one

被引:5
作者
Zeslawska, Ewa [1 ]
Nitek, Wojciech [2 ]
Tejchman, Waldemar [1 ]
Handzlik, Jadwiga [3 ]
机构
[1] Pedag Univ Cracow, Inst Biol, Dept Chem, Podchorazych 2, PL-30084 Krakow, Poland
[2] Jagiellonian Univ, Fac Chem, Gronostajowa 2, PL-30387 Krakow, Poland
[3] Jagiellonian Univ, Med Coll, Dept Technol & Biotechnol Drugs, Med 9, PL-30688 Krakow, Poland
来源
ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY | 2018年 / 74卷
关键词
hydrogen bonding; 2-amino-5-benzylideneimidazolone; rhodanine-3-propionic acid; crystal structure; efflux pump inhibitor; GRAM-NEGATIVE BACTERIA; P-GLYCOPROTEIN ABCB1; MULTIDRUG-RESISTANCE; CRYSTAL-STRUCTURES; EFFLUX PUMP; RHODANINE-3-CARBOXYLIC ACIDS; PLASMINOGEN-ACTIVATOR; DERIVATIVES; INHIBITORS; CANCER;
D O I
10.1107/S2053229618013980
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The arylidene-imidazolone derivatives are a group of compounds of great interest in medicinal chemistry due to their various pharmacological actions. In order to study the possible conformations of an arylidene-imidazolone derivative, two new crystal structures were determined by X-ray diffraction, namely (Z)-5-(4-chlorobenzylidene)-2-(4-methylpiperazin-1-yl)-3H-imidazol-5(4H)-one, C15H17ClN4O, (6), and its salt 4-[5-(4-chlorobenzylidene)-5-oxo-4,5- dihydro-3H-imidazol-2-yl]-1-methylpiperazin-1-ium3-{5-[4-(diethylamino)benzylidene]-4-oxo-2-thioxothiazolidin-3-yl} propionate, C15H18ClN4O+center dot C17H19N2O3S2-, (7). Both compounds crystallize in the space group P (1) over bar. The basic form (6) crystallizes with two molecules in the asymmetric unit. In the acid form of (6), the N atom of the piperazine ring is protonated by proton transfer from the carboxyl group of the rhodanine acid derivative. The greatest difference in the conformations of (6) and its protonated form, (6c), is observed in the location of the arylidene-imidazolone substituent at the N atom. In the case of (6c), the position of this substituent is close to axial, while for (6), the corresponding position is intermediate between equatorial and axial. The crystal packing is dominated by a network of N-H center dot center dot center dot O hydrogen bonds. Furthermore, the crystal structures are stabilized by numerous intermolecular contacts of types C-H center dot center dot center dot N and C-H center dot center dot center dot Cl in (6), and C-H center dot center dot center dot O and C-H center dot center dot center dot S in (7). The geometry with respect to the location of the substituents at the N atoms of the piperazine ring was compared with other crystal structures possessing an N-methylpiperazine moiety.
引用
收藏
页码:1427 / +
页数:23
相关论文
共 37 条
[21]   A short history of SHELX [J].
Sheldrick, George M. .
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2008, 64 :112-122
[22]  
Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930, 10.1107/S2053273314026370]
[23]  
Spengler G, 2010, ANTICANCER RES, V30, P4867
[24]   Transport proteins of the ABC family and multidrug resistance of tumor cells [J].
Stavrovskaya, A. A. ;
Stromskaya, T. P. .
BIOCHEMISTRY-MOSCOW, 2008, 73 (05) :592-604
[25]   Spectral Characteristic and Preliminary Anticancer Activity in vitro of Selected Rhodanine-3-carboxylic Acids Derivatives [J].
Stawoska, Iwona ;
Tejchman, Waldemar ;
Mazuryk, Olga ;
Lycka, Antonin ;
Nowak-Sliwinska, Patrycja ;
Zeslawska, Ewa ;
Nitek, Wojciech ;
Kania, Agnieszka .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 2017, 54 (05) :2889-2897
[26]   Antimycobacterial activity of 5-arylidene aromatic derivatives of hydantoin [J].
Szymanska, E ;
Kiec-Kononowicz, K .
FARMACO, 2002, 57 (05) :355-362
[27]   The Crystal Structures of Three Rhodanine-3-Carboxylic Acids [J].
Tejchman, Waldemar ;
Skorska-Stania, Agnieszka ;
Zeslawska, Ewa .
JOURNAL OF CHEMICAL CRYSTALLOGRAPHY, 2016, 46 (04) :181-187
[28]   The medicinal chemistry of multidrug resistance (MDR) reversing drugs [J].
Teodori, E ;
Dei, S ;
Scapecchi, S ;
Gualtieri, F .
FARMACO, 2002, 57 (05) :385-415
[29]   publCIF: software for editing, validating and formatting crystallographic information files [J].
Westrip, Simon P. .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 2010, 43 :920-925
[30]   The crystal structures of 3-TAPAP in complexes with the urokinase-type plasminogen activator and picrate [J].
Zeslawska, E ;
Jacob, U ;
Stürzebecher, J ;
Oleksyn, BJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (01) :228-234